New care model aims to save mothers and babies with sickle cell disease

NCT ID NCT05143021

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a special care program for pregnant women with sickle cell disease in Ghana. A team of obstetric and sickle cell experts works together to prevent complications and reduce deaths. Researchers will track 500 women to see if this low-cost approach improves survival and health for both mothers and babies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Multidisciplinary care program (obstetrics and sickle cell disease teams)

What this could lead to

If successful, this could provide a low-cost model to reduce maternal and infant deaths in sickle cell disease pregnancies.

What could go wrong

This is an observational study without a control group, so improvements may be due to other factors. Results may not apply outside Ghana.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pregnancy disorder sickle cell disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Greater Accra Regional Hospital

    Accra, Ghana

  • Korle Bu Teaching Hospital

    Accra, Ghana

  • Tamale Teaching Hospital

    Tamale, Ghana